Opaleye Management Inc.
CIK 0001595855 · BOSTON, MA · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$1.10B
2026 Q2
Positions
58
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
64.8%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
LQDA
LIQUIDIA CORPORATION
17.7%
ETON
ETON PHARMACEUTICALS INC
9.4%
HROW
HARROW INC
9.2%
IRON
DISC MEDICINE INC
5.7%
URGN
UROGEN PHARMA LTD
4.8%
03770N101
APOGEE THERAPEUTICS INC
4.7%
MGTX
MEIRAGTX HLDGS PLC
4.3%
SLGL
SOL-GEL TECHNOLOGIES LTD
3.4%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.